{"id":65368,"date":"2026-03-25T17:23:34","date_gmt":"2026-03-25T11:53:34","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=65368"},"modified":"2026-03-25T17:23:35","modified_gmt":"2026-03-25T11:53:35","slug":"why-is-onesource-specialty-pharma-share-price-falling","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/","title":{"rendered":"Why is Onesource Specialty Pharma Share Price Falling? Check Next Share Price Target\u00a0"},"content":{"rendered":"<p><strong>&nbsp;<\/strong><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p><p>As per the recent <a href=\"https:\/\/univest.in\/stocks\/onesource\/onesource-specl-pharma-l-share-price-today\">Onesource Specialty Pharma<\/a> share price of \u20b91,247.60, it underperformed its sector by 5.20% over the past day. The stock has declined by 13.98% over the past 5 days and declined by 3.61% over the past month. The company\u2019s financial performance in the latest quarter underscores its enduring operational resilience. These figures highlight a period of volatility and consolidation within a broader trading brand.&nbsp;<\/p><p>The stock remains liquid enough for trading, but its moving averages suggest a mixed outlook, and even the stock\u2019s recent performance. The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning underscores the prevailing negative momentum and suggests that the stock is navigating a challenging phase in terms of price stability.&nbsp;&nbsp;&nbsp;<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Key_Reasons_Behind_Onesource_Specialty_Pharma_Share_Price_Falling\" title=\"Key Reasons Behind Onesource Specialty Pharma Share Price Falling&nbsp;\">Key Reasons Behind Onesource Specialty Pharma Share Price Falling&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Onesource_Specialty_Pharma_Recent_Market_Performance\" title=\"Onesource Specialty Pharma Recent Market Performance\">Onesource Specialty Pharma Recent Market Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Onesource_Specialty_Pharma_Share_Price_Target\" title=\"Onesource Specialty Pharma Share Price Target&nbsp;\">Onesource Specialty Pharma Share Price Target&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Onesource_Specialty_Pharma_Share_Price_Target_2026\" title=\"Onesource Specialty Pharma Share Price Target 2026\">Onesource Specialty Pharma Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Below_are_Onesource_Specialty_Pharma_monthly_share_price_targets_for_2026\" title=\"Below are Onesource Specialty Pharma monthly share price targets for 2026;&nbsp;\">Below are Onesource Specialty Pharma monthly share price targets for 2026;&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Summary_of_Onesource_Specialty_Pharma_Share_Price_Target_for_2026\" title=\"Summary of Onesource Specialty Pharma Share Price Target for 2026:&nbsp;\">Summary of Onesource Specialty Pharma Share Price Target for 2026:&nbsp;<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Onesource_Specialty_Pharma_Share_Price_Target_2027\" title=\"Onesource Specialty Pharma Share Price Target 2027\">Onesource Specialty Pharma Share Price Target 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Below_are_the_Onesource_Specialty_Pharma_monthly_share_price_targets_for_2027\" title=\"Below are the Onesource Specialty Pharma monthly share price targets for 2027;&nbsp;\">Below are the Onesource Specialty Pharma monthly share price targets for 2027;&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Summary_of_Onesource_Specialty_Pharma_Share_Price_Target_for_2027\" title=\"Summary of Onesource Specialty Pharma Share Price Target for 2027:&nbsp;\">Summary of Onesource Specialty Pharma Share Price Target for 2027:&nbsp;<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Summary_of_Onesource_Specialty_Pharma_Share_Price_Target_from_2026_to_2030\" title=\"Summary of Onesource Specialty Pharma Share Price Target from 2026 to 2030&nbsp;\">Summary of Onesource Specialty Pharma Share Price Target from 2026 to 2030&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Onesource_Specialty_Pharma_Analyst_Rating\" title=\"Onesource Specialty Pharma: Analyst Rating&nbsp;\">Onesource Specialty Pharma: Analyst Rating&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Onesource_Specialty_Pharma_Future_Outlook\" title=\"Onesource Specialty Pharma Future Outlook&nbsp;\">Onesource Specialty Pharma Future Outlook&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#What_is_the_Right_Time_to_Buy_Onesource_Specialty_Pharma_Shares\" title=\"What is the Right Time to Buy Onesource Specialty Pharma Shares?&nbsp;\">What is the Right Time to Buy Onesource Specialty Pharma Shares?&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Conclusion\" title=\"Conclusion&nbsp;\">Conclusion&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#FAQs\" title=\"FAQs\">FAQs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#What_are_the_key_reasons_behind_the_Onesource_Specialty_Pharma_share_price_fall\" title=\"What are the key reasons behind the Onesource Specialty Pharma share price fall?&nbsp;\">What are the key reasons behind the Onesource Specialty Pharma share price fall?&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#What_is_the_Onesource_Specialty_Pharma_share_price_target\" title=\"What is the Onesource Specialty Pharma share price target?&nbsp;\">What is the Onesource Specialty Pharma share price target?&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#What_are_the_factors_affecting_Onesource_Specialty_Pharma_shares\" title=\"What are the factors affecting Onesource Specialty Pharma shares?&nbsp;\">What are the factors affecting Onesource Specialty Pharma shares?&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Is_Onesource_Specialty_Pharma_a_good_share_to_buy\" title=\"Is Onesource Specialty Pharma a good share to buy?&nbsp;\">Is Onesource Specialty Pharma a good share to buy?&nbsp;<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/why-is-onesource-specialty-pharma-share-price-falling\/#Also_Read\" title=\"Also Read\">Also Read<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Reasons_Behind_Onesource_Specialty_Pharma_Share_Price_Falling\"><\/span><strong>Key Reasons Behind Onesource Specialty Pharma Share Price Falling&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Tap to Access Best Research Pieces<\/strong><\/a><\/p><p><strong>There are several reasons behind the Onesource Specialty Pharma share price falling, including Weak Q3 FY26 Financial Results, Delay in Semaglutide Approval (Canada), Revenue Shortfall Due to Client Approval Delays, Bearish Technical Indicators, and&nbsp; Downgrade by Analysts \/ Strong Sell Rating.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/strong><\/p><p><strong>Below are the key reasons behind the Onesource Specialty Pharma share price fall:&nbsp;<\/strong><\/p><ul class=\"wp-block-list\"><li><strong>Weak Q3 FY26 Financial Results: <\/strong>One of the main reasons for the fall was the company&#8217;s poor quarterly performance. OneSource reported a net loss of around \u20b947-88 crore, unlike the profits earned in earlier quarters, along with a sharp 26% fall in revenue.<\/li>\n\n<li><strong>Delay in Semaglutide Approval (Canada):<\/strong> However, one of the major operational issues was the company\u2019s inability to generate revenue due to the delay in semaglutide&#8217;s approval in Canada. The company was looking forward to the launch of this drug, which would have significantly helped it generate revenue.<\/li><\/ul><ul class=\"wp-block-list\"><li><strong>&nbsp;Revenue Shortfall Due to Client Approval Delays: <\/strong>Besides the issue of semaglutide, the company also witnessed delays in the conversion of the company\u2019s service agreement into a commercial supply agreement with one of the key customers.&nbsp;<\/li>\n\n<li><strong>Bearish Technical Indicators:<\/strong> From a technical standpoint, the stock has shown clear bearish signals. It is trading below key moving averages, such as the 50-day and 200-day, indicating a downtrend. Technical downgrades and negative momentum often trigger algorithmic and trader-driven selling, further pushing the price down.&nbsp;<\/li>\n\n<li><strong>&nbsp;Downgrade by Analysts \/ Strong Sell Rating: <\/strong>The stock has also been downgraded to a \u201cStrong Sell\u201d rating by some analysts due to deteriorating fundamentals, weak profitability, and an expensive valuation relative to returns. Such downgrades influence institutional sentiment and can accelerate selling pressure.&nbsp;<\/li><\/ul><p><em>Download the <\/em><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><em>Univest iOS App<\/em><\/a><em> or the <\/em><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><em>Univest Android App<\/em><\/a><em> to get daily stock recommendations and insightful research pieces!<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onesource_Specialty_Pharma_Recent_Market_Performance\"><\/span><strong>Onesource Specialty Pharma Recent Market Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The recent Onesource Specialty Pharma share price stands at \u20b91,245.60, down 5.59% over the past day. The broader Sensex index also declined, though less severely, previously closed at 1,316.10, underscoring that Onesource Specialty Pharma movement was more acute than the general market trend. The Onesource Specialty Pharma share price has declined by 3.80% over the past month and by 28.69% over the past six months. The 52-week high of Onesource Specialty Pharma is \u20b92,248.00, and the 52-week low of Onesource Specialty Pharma is \u20b91,057.00.&nbsp;<\/p><p>Note: <em>For the live Onesource Specialty Pharma Share Price Target, visit the univest app and check the stock fundamentals.<\/em>&nbsp;&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onesource_Specialty_Pharma_Share_Price_Target\"><\/span><strong>Onesource Specialty Pharma Share Price Target&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Onesource Specialty Pharma has an average share price target of 1,278.14. The consensus estimate represents an upside of 15.78% from the last price of 1,246.10. View the 14 reports from 8 analysts offering long-term price targets for Onesource Specialty Pharma. The consensus rating for Onesource Specialty Pharma is Neutral, based on insights from 12 analysts; 6 recommend buying, 3 suggest selling, and 3 recommend holding. Latest broker research reports have recommended buy, sell, and hold with the forecasted share price targets.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onesource_Specialty_Pharma_Share_Price_Target_2026\"><\/span><strong>Onesource Specialty Pharma Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As per the technical data, the minimum Onesource Specialty Pharma share price target is \u20b91,278.14, and the maximum price that Onesource Specialty Pharma shares can reach is \u20b91,298.56.&nbsp;<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Below_are_Onesource_Specialty_Pharma_monthly_share_price_targets_for_2026\"><\/span><strong>Below are Onesource Specialty Pharma monthly share price targets for 2026;&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Months<\/strong><\/td><td><strong>Price Target<\/strong><\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for March 2026<\/strong><\/td><td>\u20b91,284.90<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for April 2026<\/strong><\/td><td>\u20b91,297.12<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for May 2026<\/strong><\/td><td>\u20b91,301.67<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for June 2026<\/strong><\/td><td>\u20b91,321.80<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for July 2026<\/strong><\/td><td>\u20b91,342.80<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for August 2026<\/strong><\/td><td>\u20b91,345.80<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for September 2026<\/strong><\/td><td>\u20b91,352.70<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for October 2026<\/strong><\/td><td>\u20b91,360.12<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for November 2026<\/strong><\/td><td>\u20b91,362.75<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for December 2026<\/strong><\/td><td>\u20b91,370.99<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Summary_of_Onesource_Specialty_Pharma_Share_Price_Target_for_2026\"><\/span><strong>Summary of Onesource Specialty Pharma Share Price Target for 2026:&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ul class=\"wp-block-list\"><li>The initial Onesource Specialty Pharma share price target for 2026 was projected to be \u20b91,254.70.&nbsp;<\/li>\n\n<li>With favourable market conditions, the Onesource Specialty Pharma mid-year share price target could reach \u20b91,275.10.<\/li>\n\n<li>By the end of 2026, the Onesource Specialty Pharma share price target is expected to reach \u20b91,285.23, indicating bullish market trends in the near future.&nbsp;<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onesource_Specialty_Pharma_Share_Price_Target_2027\"><\/span><strong>Onesource Specialty Pharma Share Price Target 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>After using Fibonacci Projections, the estimated first half of the year Onesource Specialty Pharma share price target is expected to reach between \u20b91242.23-\u20b91610.05, and the maximum value that shares of Onesource Specialty Pharma can reach is \u20b91803.09.&nbsp;<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Below_are_the_Onesource_Specialty_Pharma_monthly_share_price_targets_for_2027\"><\/span><strong>Below are the Onesource Specialty Pharma monthly share price targets for 2027;&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Months<\/strong><\/td><td><strong>Price Target<\/strong><\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for January 2027<\/strong><\/td><td>\u20b91,454.03<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for February 2027<\/strong><\/td><td>\u20b91,485.00<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for March 2027<\/strong><\/td><td>\u20b91,513.54<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for April 2027<\/strong><\/td><td>\u20b91,548.40<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for May 2027<\/strong><\/td><td>\u20b91,579.09<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for June 2027<\/strong><\/td><td>\u20b91,610.05<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for July 2027<\/strong><\/td><td>\u20b91,642.29<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for August 2027<\/strong><\/td><td>\u20b91671.99<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for September 2027<\/strong><\/td><td>\u20b91,700.86<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for October 2027<\/strong><\/td><td>\u20b91,735.18<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for November 2027<\/strong><\/td><td>\u20b91,768.68<\/td><\/tr><tr><td><strong>Onesource Specialty Pharma share price target for December 2027<\/strong><\/td><td>\u20b91,803.09<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Summary_of_Onesource_Specialty_Pharma_Share_Price_Target_for_2027\"><\/span><strong>Summary of Onesource Specialty Pharma Share Price Target for 2027:&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ul class=\"wp-block-list\"><li>The initial Onesource Specialty Pharma share price target for 2027 was \u20b91,454.03.&nbsp;<\/li>\n\n<li>With favourable market conditions, the mid-year Onesource Specialty Pharma share price target could reach \u20b91,610.05.<\/li>\n\n<li>By the end of 2027, the Onesource Specialty Pharma share price target is expected to reach \u20b91,803.09, indicating bullish market trends in the near future.&nbsp;<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Summary_of_Onesource_Specialty_Pharma_Share_Price_Target_from_2026_to_2030\"><\/span><strong>Summary of Onesource Specialty Pharma Share Price Target from 2026 to 2030&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><strong>Here\u2019s the summary of the Onesource Specialty Pharma share price target from 2026 to 2030:&nbsp;<\/strong><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Year&nbsp;<\/strong><\/td><td><strong>Initial Target&nbsp;<\/strong><\/td><td><strong>Mid-Year<\/strong><\/td><td><strong>Year-End Target<\/strong><\/td><\/tr><tr><td><strong>2026<\/strong><\/td><td>\u20b91,150.73<\/td><td>\u20b91,274.21<\/td><td>\u20b91,426.99<\/td><\/tr><tr><td><strong>2027<\/strong><\/td><td>\u20b91,454.03<\/td><td>\u20b91,610.05<\/td><td>\u20b91,803.09<\/td><\/tr><tr><td><strong>2028<\/strong><\/td><td>\u20b91,837.26<\/td><td>\u20b92,034.41<\/td><td>\u20b92,278.33<\/td><\/tr><tr><td><strong>2029<\/strong><\/td><td>\u20b92,321.50<\/td><td>\u20b92,570.62<\/td><td>\u20b92,878.83<\/td><\/tr><tr><td><strong>2030<\/strong><\/td><td>\u20b92,933.38<\/td><td>\u20b93,248.15<\/td><td>\u20b93,637.59<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onesource_Specialty_Pharma_Analyst_Rating\"><\/span><strong>Onesource Specialty Pharma: Analyst Rating&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>The average 12-month price target is \u20b91,150.73, and the consensus rating is Hold (a mix of Buy, Hold, &amp; Sell).&nbsp;<\/li>\n\n<li>The analyst&#8217;s target range is between \u20b91,150.73 and \u20b91,426.99.&nbsp;<\/li>\n\n<li>According to some analysts, concerns remain about a \u2018Reduce\u2019 call at 1,426.99.&nbsp;<\/li>\n\n<li>The analyst&#8217;s sentiment is mixed; there have been recent bullish calls (ICICI, JM), but also cautious ones (Motilal Oswal, Nuvama).&nbsp;<\/li><\/ul><p>Note: <em>For the live Onesource Specialty Pharma Share Price Target, visit the univest app and check the stock fundamentals.<\/em>&nbsp;&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onesource_Specialty_Pharma_Future_Outlook\"><\/span><strong>Onesource Specialty Pharma Future Outlook&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/25172320\/Onesource-Specialty-Pharma-Limited-1024x536.jpg\" alt=\"Onesource Specialty Pharma Limited\" class=\"wp-image-65451\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/25172320\/Onesource-Specialty-Pharma-Limited-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/25172320\/Onesource-Specialty-Pharma-Limited-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/25172320\/Onesource-Specialty-Pharma-Limited-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/25172320\/Onesource-Specialty-Pharma-Limited-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/25172320\/Onesource-Specialty-Pharma-Limited-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/25172320\/Onesource-Specialty-Pharma-Limited-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/25172320\/Onesource-Specialty-Pharma-Limited.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>While the recent trading activity in Onesource Specialty Pharma highlights fluctuating volatility and investor interest, the prevailing downward price trend and volume concentration near lows suggest caution. Onesource Specialty Pharma is forecast to grow earnings and revenue by 115.8% and 42.7% per annum, respectively. EPS is expected to grow by 120.30% per annum. Return on equity is forecast to be 12.60% in 3 years.&nbsp;<\/p><p>Investors and other market participants may find value in monitoring delivery volumes with the prevailing price movements. The bank has a high valuation, with a high Price-to-Book Value, leading to high market volatility relative to its risk-based assets.&nbsp;<\/p><p><strong><em>Also Read: <\/em><\/strong><a href=\"https:\/\/univest.in\/blogs\/why-is-rain-industries-share-price-falling\"><strong><em>Why is Rain Industries&#8217; Share Price Falling?&nbsp;<\/em><\/strong><\/a><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_Right_Time_to_Buy_Onesource_Specialty_Pharma_Shares\"><\/span><strong>What is the Right Time to Buy Onesource Specialty Pharma Shares?&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>According to analysts, the Onesource Specialty Pharma share price is determined by market factors. The share price has decreased due to internal company factors, as discussed above. Therefore, investors must review all relevant factors before investing in Onesource Specialty Pharma. There are some factors to consider before investing in Onesource Specialty Pharma shares.<\/p><ul class=\"wp-block-list\"><li><strong>Strong Fundamentals: <\/strong>Investors should review Onesource Specialty Pharma Company\u2019s fundamentals before investing. If a company has strong fundamentals, high profitability, and effective management, then investors should consider investing in it.&nbsp;&nbsp;&nbsp;&nbsp;<\/li>\n\n<li><strong>Financing Partnerships: <\/strong>Financing partnerships bridge the gap between customers and financial institutions, facilitating the distribution of a wide range of products and generating positive sales revenue for many consumers.&nbsp;&nbsp;&nbsp;<\/li>\n\n<li><strong>Growth in the Pharma sector: <\/strong>The company is well-positioned to deliver benefits to Onesource Specialty Pharma. This dominant sector increases demand and prices for Onesource Specialty Pharma.<\/li>\n\n<li><strong>Highly Volatile: <\/strong>Prices are highly volatile, leading to significant price swings that substantially affect Onesource Specialty Pharma stock price. Investors must review the market structure before investing in Onesource Specialty Pharma Company shares.&nbsp;<\/li><\/ul><p>Note: <em>For the live Onesource Specialty Pharma Share Price Target, visit the univest app and check the stock fundamentals.<\/em>&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>To summarise, Onesource Specialty Pharma opened at \u20b91,159.20, down 5.48% from the previous close, marking the lowest intraday level as well. The Onesource Specialty Pharma&#8217; share performance underperformed both its sector and the broader market, continuing a sequence of declines over the recent sessions. Technical indicators predominantly point to a cautious market assessment, with the stock trading below all moving averages and exhibiting bearish momentum.&nbsp;&nbsp;&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span><strong>FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_are_the_key_reasons_behind_the_Onesource_Specialty_Pharma_share_price_fall\"><\/span><strong>What are the key reasons behind the Onesource Specialty Pharma share price fall?&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ol class=\"wp-block-list\"><li><\/li><\/ol><p>There are several reasons behind the Onesource Specialty Pharma share price falling, including Weak Q3 FY26 Financial Results, Delay in Semaglutide Approval (Canada), Revenue Shortfall Due to Client Approval Delays, Bearish Technical Indicators, and&nbsp; Downgrade by Analysts \/ Strong Sell Rating. However, one of the major operational issues was the company\u2019s inability to generate revenue due to the delay in semaglutide&#8217;s approval in Canada.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_Onesource_Specialty_Pharma_share_price_target\"><\/span><strong>What is the Onesource Specialty Pharma share price target?&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ol start=\"2\" class=\"wp-block-list\"><li><\/li><\/ol><p>Onesource Specialty Pharma has an average share price target of 1,278.14. The consensus estimate represents an upside of 15.78% from the last price of 1,246.10. View the 14 reports from 8 analysts offering long-term price targets for Onesource Specialty Pharma. The consensus rating for Onesource Specialty Pharma is Neutral, based on insights from 12 analysts; 6 recommend buying, 3 suggest selling, and 3 recommend holding.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_are_the_factors_affecting_Onesource_Specialty_Pharma_shares\"><\/span><strong>What are the factors affecting Onesource Specialty Pharma shares?&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ol start=\"3\" class=\"wp-block-list\"><li><\/li><\/ol><p>According to analysts, the Onesource Specialty Pharma share price is determined by market factors. The share price has decreased due to internal company factors, as discussed above. Therefore, investors must review all relevant factors before investing in Onesource Specialty Pharma. There are some factors to consider before investing in Onesource Specialty Pharma Company shares. Financing partnerships bridge the gap between customers and financial institutions, facilitating the distribution of a wide range of products and generating positive sales revenue for many consumers.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Is_Onesource_Specialty_Pharma_a_good_share_to_buy\"><\/span><strong>Is Onesource Specialty Pharma a good share to buy?&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ol start=\"4\" class=\"wp-block-list\"><li><\/li><\/ol><p>While the recent trading activity in Onesource Specialty Pharma highlights fluctuating volatility and investor interest, the prevailing downward price trend and volume concentration near lows suggest caution. Investors and other market participants may find value in monitoring delivery volumes with the prevailing price movements. The bank has a high valuation, with a high Price-to-Book Value, leading to high market volatility relative to its risk-based assets.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Also_Read\"><\/span><strong>Also Read<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/why-is-krbl-share-price-falling\"><strong>Why is KRBL Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-reliance-infrastructures-share-price-falling\"><strong>Why is Reliance Infrastructures Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-mahanagar-gas-share-price-falling\"><strong>Why is Mahanagar Gas Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-happiest-minds-share-price-falling\"><strong>Why is Happiest Minds Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp;Click Here &#8211; Get Free Investment Predictions As per the recent Onesource Specialty Pharma share price of \u20b91,247.60, it underperformed its sector by 5.20% over the past day. The stock has declined by 13.98% over the past 5 days and declined by 3.61% over the past month. The company\u2019s financial performance in the latest quarter<\/p>\n","protected":false},"author":28,"featured_media":65450,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3862],"class_list":["post-65368","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-q4-results-expectations"],"metadata":{"_edit_lock":["1774439646:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["75"],"rank_math_description":["Check why the Onesource Specialty Pharma share price falling with short-term and long-term share price targets. Know what analysts expect from the Onesource Specialty Pharma share price movements."],"rank_math_title":["Why is Onesource Specialty Pharma Share Price Falling: Key Reasons and Share Price Target"],"rank_math_focus_keyword":["Onesource Specialty Pharma Share Price Falling"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"amazonS3_cache":["a:4:{s:86:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/03\/Onesource-Specialty-Pharma-Limited.jpg\";a:2:{s:2:\"id\";i:65451;s:11:\"source_type\";s:13:\"media-library\";}s:95:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/03\/Onesource-Specialty-Pharma-Limited-1024x536.jpg\";a:2:{s:2:\"id\";i:65451;s:11:\"source_type\";s:13:\"media-library\";}s:118:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/25172320\/Onesource-Specialty-Pharma-Limited.jpg\";a:2:{s:2:\"id\";i:65451;s:11:\"source_type\";s:13:\"media-library\";}s:127:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/25172320\/Onesource-Specialty-Pharma-Limited-1024x536.jpg\";a:2:{s:2:\"id\";i:65451;s:11:\"source_type\";s:13:\"media-library\";}}"],"_thumbnail_id":["65450"],"rank_math_analytic_object_id":["7180"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/25172238\/Why-is-Onesource-Specialty-Pharma-Share-Price-Falling-Key-Reasons-and-Share-Price-Target.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/65368","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=65368"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/65368\/revisions"}],"predecessor-version":[{"id":65452,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/65368\/revisions\/65452"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/65450"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=65368"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=65368"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=65368"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}